Current Diabetes Reports

, Volume 5, Issue 1, pp 24–29

Peripheral arterial disease: Clinical assessment and indications for revascularization in the patient with diabetes

  • Bart E. Muhs
  • Paul Gagne
  • Peter Sheehan
Article

Abstract

Peripheral arterial disease (PAD) is an under-recognized complication of diabetes. Recently, prevalence estimates in patients with diabetes over 50 years of age have been placed at 25% to 30%. The main reason for under-reporting is the largely asymptomatic nature of PAD in diabetes. Nonetheless, it is important to diagnose PAD because it is a marker of systemic atherosclerosis with excess cardiovascular risk, and it may identify a patient who may develop progressive disability and risk of limb loss. The most sensitive and specific diagnostic tool is an ankle-brachial index. Imaging studies are performed in patients who are candidates for revascularization. The most durable and effective revascularization procedure for PAD in diabetes is surgical bypass with saphenous vein as the conduit. Endovascular interventions are best used in patients with proximal disease with short-segment stenoses. The indications for revascularization have been immutable for decades, namely rest pain, ischemic ulceration, or gangrene. Presently, clinicians would include "selected" patients with intermittent claudication who have disabling symptoms and proximal disease above the inguinal ligament.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Dormandy JA, Rutherford RB: Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Concensus (TASC). J Vasc Surg 2000, 31(1 Pt 2):S1-S296.PubMedCrossRefGoogle Scholar
  2. 2.
    Kannel WB: Risk factors for atherosclerotic cardiovascular outcomes in different arterial territories. J Cardiovasc Risk 1994, 1:333–339.PubMedCrossRefGoogle Scholar
  3. 3.
    Hirsch AT, Criqui MH, Treat-Jacobson D: Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001, 286:1317–1324.PubMedCrossRefGoogle Scholar
  4. 4.
    Elhadd TA, Jung RT, Stonebridge PA, Belch JF: Pilot study of prevalence of asymptomatic peripheral arterial occlusive disease in patients with diabetes attending a hospital clinic. Practical Diabetes Int 1999, 16:163–166.CrossRefGoogle Scholar
  5. 5.
    Beckman JA, Creager MA, Libby P: Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 2002, 287:2570–2581.PubMedCrossRefGoogle Scholar
  6. 6.
    Schneider DL, Sobel BE: Diabetes and Thrombosis. Edited by Johnstone M, Veves A. Totowa, NJ: Humana Press; 2001.Google Scholar
  7. 7.
    LoGerfo FW, Coffman JD: Current concepts. Vascular and microvascular disease of the foot in diabetes. Implications for foot care. N Engl J Med 1984, 311:1615–1619.PubMedCrossRefGoogle Scholar
  8. 8.
    Dolan NC, Liu K, Criqui MH, et al.: Peripheral artery disease, diabetes, and reduced lower extremity functioning. Diabetes Care 2002, 25:113–120.PubMedCrossRefGoogle Scholar
  9. 9.
    A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee [no authors listed]. Lancet 1996, 348:1329-1339.Google Scholar
  10. 10.
    Weitz JI, Byrne J, Clagett GP, et al.: Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. Circulation 1996, 94:3026–3049.PubMedGoogle Scholar
  11. 11.
    American Diabetes Association: Peripheral arterial disease in people with diabetes. Diabetes Care 2003, 26:3333–3341. An American College of Cardiology and American Diabetes Association initiative of experts with a consensus statement on the epidemiology, biology, assessment, and management of PAD in patients with diabetes.CrossRefGoogle Scholar
  12. 12.
    Teodorescu VJ, Chen C, Morrissey N, et al.: Detailed protocol of ischemia and the use of noninvasive vascular laboratory testing in diabetic foot ulcers. Am J Surg 2004, 187:75S-80S.PubMedCrossRefGoogle Scholar
  13. 13.
    Andros G, Harris RW, Dulawa LB, et al.: The need for arteriography in diabetic patients with gangrene and palpable foot pulses. Arch Surg 1984, 119:1260–1263.PubMedGoogle Scholar
  14. 14.
    Caputo GM, Cavanagh PR, Ulbrecht JS, et al.: Assessment and management of foot disease in patients with diabetes. N Engl J Med 1994, 331:854–860.PubMedCrossRefGoogle Scholar
  15. 15.
    Pomposelli FB Jr, Jepsen SJ, Gibbons GW, et al.: Efficacy of the dorsal pedal bypass for limb salvage in diabetic patients: short-term observations. J Vasc Surg 1990, 11:745–751; discussion 751–752.PubMedCrossRefGoogle Scholar
  16. 16.
    Akbari CM, Pomposelli FB Jr, Gibbons GW, et al.: Lower extremity revascularization in diabetes: late observations. Arch Surg 2000, 135:452–456.PubMedCrossRefGoogle Scholar
  17. 17.
    Hamdan AD, Rayan SS, Hook SC, et al.: Bypasses to tibial vessels using polytetrafluoroethylene as the solo conduit in a predominantly diabetic population. Vasc Endovascular Surg 2002, 36:59–63.PubMedGoogle Scholar
  18. 18.
    Akbari CM, LoGerfo FW: Diabetes and peripheral vascular disease. J Vasc Surg 1999, 30:373–384.PubMedCrossRefGoogle Scholar
  19. 19.
    Faries PL, LoGerfo FW, Hook SC, et al.: The impact of diabetes on arterial reconstructions for multilevel arterial occlusive disease. Am J Surg 2001, 181:251–255.PubMedCrossRefGoogle Scholar
  20. 20.
    Faries PL, Brophy D, LoGerfo FW, et al.: Combined iliac angioplasty and infrainguinal revascularization surgery are effective in diabetic patients with multilevel arterial disease. Ann Vasc Surg 2001, 15:67–72.PubMedGoogle Scholar
  21. 21.
    Ballotta E, Renon L, Toffano M, et al.: Patency and limb salvage rates after distal revascularization to unclampable calcified outflow arteries. J Vasc Surg 2004, 39:539–546.PubMedCrossRefGoogle Scholar
  22. 22.
    Johnston KW, Rae M, Hogg-Johnston SA, et al.: 5-year results of a prospective study of percutaneous transluminal angioplasty. Ann Surg 1987, 2061:403–413.CrossRefGoogle Scholar
  23. 23.
    Palmaz JC, Laborde JC, Rivera FJ, et al.: Stenting of the iliac arteries with the Palmaz stent: experience from a multicenter trial. Cardiovasc Intervent Radiol 1992, 15:291–297.PubMedGoogle Scholar
  24. 24.
    Bosch JL, Hunink MG: Meta-analysis of the results of percutaneous transluminal angioplasty and stent placement for aortoiliac occlusive disease. Radiology 1997, 204:87–96.PubMedGoogle Scholar
  25. 25.
    Cambria RP, Faust G, Gusberg R, et al.: Percutaneous angioplasty for peripheral arterial occlusive disease. Correlates of clinical success. Arch Surg 1987, 122:283–287.PubMedGoogle Scholar
  26. 26.
    Jeans WD, Cole SE, Horrocks M, Baird RN: Angioplasty gives good results in critical lower limb ischaemia. A 5-year followup in patients with known ankle pressure and diabetic status having femoropopliteal dilations. Br J Radiol 1994, 67:123–128.PubMedCrossRefGoogle Scholar
  27. 27.
    van der Zaag ES, Legemate DA, Prins MH, et al.: Angioplasty or bypass for superficial femoral artery disease? A randomised controlled trial. Eur J Vasc Endovasc Surg 2004, 28:132–137.PubMedGoogle Scholar
  28. 28.
    Lofberg AM, Karacagil S, Ljungman C, et al.: Percutaneous transluminal angioplasty of the femoropopliteal arteries in limbs with chronic critical lower limb ischemia. J Vasc Surg 2001, 34:114–121.PubMedCrossRefGoogle Scholar
  29. 29.
    Gray BH, Sullivan TM, Childs MB, et al.: High incidence of restenosis/reocclusion of stents in the percutaneous treatment of long-segment superficial femoral artery disease after suboptimal angioplasty. J Vasc Surg 1997, 25:74–83.PubMedCrossRefGoogle Scholar
  30. 30.
    Saxon RR, Coffman JM, Gooding JM, et al.: Long-term results of ePTFE stent-graft versus angioplasty in the femoropopliteal artery: single center experience from a prospective, randomized trial. J Vasc Interv Radiol 2003, 14:303–311.PubMedGoogle Scholar
  31. 31.
    Parsons RE, Suggs WD, Lee JJ, et al.: Percutaneous transluminal angioplasty for the treatment of limb threatening ischemia: do the results justify an attempt before bypass grafting? J Vasc Surg 1998, 28:1066–1071.PubMedCrossRefGoogle Scholar
  32. 32.
    Bolia A, Brennan J, Bell PR: Recanalisation of femoropopliteal occlusions: improving success rate by subintimal recanalisation. Clin Radiol 1989, 40:325.PubMedCrossRefGoogle Scholar
  33. 33.
    Vraux H, Hammer F, Verhelst R, et al.: Subintimal angioplasty of tibial vessel occlusions in the treatment of critical limb ischaemia: mid-term results. Eur J Vasc Endovasc Surg 2000, 20:441–446.PubMedCrossRefGoogle Scholar
  34. 34.
    Desgranges P, Boufi M, Lapeyre M, et al.: Subintimal angioplasty: feasible and durable. Eur J Vasc Endovasc Surg 2004, 28:138–141.PubMedGoogle Scholar
  35. 35.
    Reekers JA, Kromhout JG, Jacobs MJ: Percutaneous intentional extraluminal recanalisation of the femoropopliteal artery. Eur J Vasc Surg 1994, 8:723–728.PubMedCrossRefGoogle Scholar
  36. 36.
    London NJ, Srinivasan R, Naylor AR, et al.: Subintimal angioplasty of femoropopliteal artery occlusions: the long-term results. Eur J Vasc Surg 1994, 8:148–155.PubMedCrossRefGoogle Scholar
  37. 37.
    Bolia A: Percutaneous intentional extraluminal (subintimal) recanalization of crural arteries. Eur J Radiol 1998, 28:199–204.PubMedCrossRefGoogle Scholar
  38. 38.
    Lipsitz EC, Ohki T, Veith FJ, et al.: Does subintimal angioplasty have a role in the treatment of severe lower extremity ischemia? J Vasc Surg 2003, 37:386–391.PubMedCrossRefGoogle Scholar
  39. 39.
    Duda SH, Poerner TC, Wiesinger B, et al.: Drug-eluting stents: potential applications for peripheral arterial occlusive disease. J Vasc Interv Radiol 2003, 14:291–301.PubMedGoogle Scholar
  40. 40.
    Sousa JE, Costa MA, Abizaid AC, et al.: Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up. Circulation 2001, 104:2007–2011.PubMedGoogle Scholar
  41. 41.
    Sousa JE, Costa MA, Abizaid A, et al.: Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation 2001, 103:192–195.PubMedGoogle Scholar
  42. 42.
    Duda SH, Pusich B, Richter G, et al.: Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results. Circulation 2002, 106:1505–1509.PubMedCrossRefGoogle Scholar

Copyright information

© Current Science Inc. 2005

Authors and Affiliations

  • Bart E. Muhs
  • Paul Gagne
  • Peter Sheehan
    • 1
  1. 1.Diabetes Foot & Ankle CenterHospital for Joint DiseasesNew YorkUSA

Personalised recommendations